King's College London

Research portal

Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study

Research output: Contribution to journalArticle

Standard

Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study. / Yanes, Manar; Santoni, Giola; Maret-Ouda, John; Ness-Jensen, Eivind; Färkkilä, Martti; Lynge, Elsebeth; Nwaru, Bright; Pukkala, Eero; Romundstad, Pål; Tryggvadóttir, Laufey; von Euler-Chelpin, My; Lagergren, Jesper.

In: European Journal of Cancer, Vol. 138, 10.2020, p. 80-88.

Research output: Contribution to journalArticle

Harvard

Yanes, M, Santoni, G, Maret-Ouda, J, Ness-Jensen, E, Färkkilä, M, Lynge, E, Nwaru, B, Pukkala, E, Romundstad, P, Tryggvadóttir, L, von Euler-Chelpin, M & Lagergren, J 2020, 'Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study', European Journal of Cancer, vol. 138, pp. 80-88. https://doi.org/10.1016/j.ejca.2020.07.018

APA

Yanes, M., Santoni, G., Maret-Ouda, J., Ness-Jensen, E., Färkkilä, M., Lynge, E., Nwaru, B., Pukkala, E., Romundstad, P., Tryggvadóttir, L., von Euler-Chelpin, M., & Lagergren, J. (2020). Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study. European Journal of Cancer, 138, 80-88. https://doi.org/10.1016/j.ejca.2020.07.018

Vancouver

Yanes M, Santoni G, Maret-Ouda J, Ness-Jensen E, Färkkilä M, Lynge E et al. Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study. European Journal of Cancer. 2020 Oct;138:80-88. https://doi.org/10.1016/j.ejca.2020.07.018

Author

Yanes, Manar ; Santoni, Giola ; Maret-Ouda, John ; Ness-Jensen, Eivind ; Färkkilä, Martti ; Lynge, Elsebeth ; Nwaru, Bright ; Pukkala, Eero ; Romundstad, Pål ; Tryggvadóttir, Laufey ; von Euler-Chelpin, My ; Lagergren, Jesper. / Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study. In: European Journal of Cancer. 2020 ; Vol. 138. pp. 80-88.

Bibtex Download

@article{9afcf50fd23444139c359a4297367618,
title = "Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study",
abstract = "Introduction: Airway micro-aspiration might contribute to the proposed associations between gastroesophageal reflux disease (GERD) and some lung diseases, including lung cancer. This study aimed to examine the hypothesis that antireflux surgery decreases the risk of small cell carcinoma, squamous cell carcinoma and adenocarcinoma of the lung differently depending on their location in relation to micro-aspiration. Methods: Population-based cohort study including patients having undergone antireflux surgery during 1980–2014 in Denmark, Finland, Iceland, Norway or Sweden. Patients having undergone antireflux surgery were compared with two groups: 1) the corresponding background population, by calculating standardised incidence ratios (SIRs) with 95% confidence intervals (CIs) and 2) non-operated GERD-patients, by calculating hazard ratios (HRs) with 95% CIs using multivariable Cox regression with adjustment for sex, age, calendar period, country, chronic obstructive pulmonary disease and obesity diagnosis or type 2 diabetes. Results: Among all 812,617 GERD-patients, 46,996 (5.8%) had undergone antireflux surgery. The SIRs were statistically significantly decreased for small cell carcinoma (SIR = 0.57, 95% CI 0.41–0.77) and squamous cell carcinoma (SIR = 0.75, 95% CI 0.60–0.92), but not for adenocarcinoma of the lung (SIR = 0.90, 95% CI 0.76–1.06). The HRs were also below unity for small cell carcinoma (HR = 0.63, 95% CI 0.44–0.90) and squamous cell carcinoma (HR = 0.80, 95% CI 0.62–1.03), but not for adenocarcinoma of the lung (HR = 1.03, 95% CI 0.84–1.26). Analyses restricted to patients with objective GERD (reflux oesophagitis or Barrett's oesophagus) showed similar results. Conclusions: This all-Nordic study indicates that patients who undergo antireflux surgery are at decreased risk of small cell carcinoma and squamous cell carcinoma of the lung, but not of adenocarcinoma of the lung.",
keywords = "Bronchus, Fundoplication, GERD, GORD, Neoplasm, Nissen, Pulmonary",
author = "Manar Yanes and Giola Santoni and John Maret-Ouda and Eivind Ness-Jensen and Martti F{\"a}rkkil{\"a} and Elsebeth Lynge and Bright Nwaru and Eero Pukkala and P{\aa}l Romundstad and Laufey Tryggvad{\'o}ttir and {von Euler-Chelpin}, My and Jesper Lagergren",
year = "2020",
month = oct,
doi = "10.1016/j.ejca.2020.07.018",
language = "English",
volume = "138",
pages = "80--88",
journal = "European Journal of Cancer",
issn = "1879-0852",
publisher = "Elsevier Limited",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Antireflux surgery and risk of lung cancer by histological type in a multinational cohort study

AU - Yanes, Manar

AU - Santoni, Giola

AU - Maret-Ouda, John

AU - Ness-Jensen, Eivind

AU - Färkkilä, Martti

AU - Lynge, Elsebeth

AU - Nwaru, Bright

AU - Pukkala, Eero

AU - Romundstad, Pål

AU - Tryggvadóttir, Laufey

AU - von Euler-Chelpin, My

AU - Lagergren, Jesper

PY - 2020/10

Y1 - 2020/10

N2 - Introduction: Airway micro-aspiration might contribute to the proposed associations between gastroesophageal reflux disease (GERD) and some lung diseases, including lung cancer. This study aimed to examine the hypothesis that antireflux surgery decreases the risk of small cell carcinoma, squamous cell carcinoma and adenocarcinoma of the lung differently depending on their location in relation to micro-aspiration. Methods: Population-based cohort study including patients having undergone antireflux surgery during 1980–2014 in Denmark, Finland, Iceland, Norway or Sweden. Patients having undergone antireflux surgery were compared with two groups: 1) the corresponding background population, by calculating standardised incidence ratios (SIRs) with 95% confidence intervals (CIs) and 2) non-operated GERD-patients, by calculating hazard ratios (HRs) with 95% CIs using multivariable Cox regression with adjustment for sex, age, calendar period, country, chronic obstructive pulmonary disease and obesity diagnosis or type 2 diabetes. Results: Among all 812,617 GERD-patients, 46,996 (5.8%) had undergone antireflux surgery. The SIRs were statistically significantly decreased for small cell carcinoma (SIR = 0.57, 95% CI 0.41–0.77) and squamous cell carcinoma (SIR = 0.75, 95% CI 0.60–0.92), but not for adenocarcinoma of the lung (SIR = 0.90, 95% CI 0.76–1.06). The HRs were also below unity for small cell carcinoma (HR = 0.63, 95% CI 0.44–0.90) and squamous cell carcinoma (HR = 0.80, 95% CI 0.62–1.03), but not for adenocarcinoma of the lung (HR = 1.03, 95% CI 0.84–1.26). Analyses restricted to patients with objective GERD (reflux oesophagitis or Barrett's oesophagus) showed similar results. Conclusions: This all-Nordic study indicates that patients who undergo antireflux surgery are at decreased risk of small cell carcinoma and squamous cell carcinoma of the lung, but not of adenocarcinoma of the lung.

AB - Introduction: Airway micro-aspiration might contribute to the proposed associations between gastroesophageal reflux disease (GERD) and some lung diseases, including lung cancer. This study aimed to examine the hypothesis that antireflux surgery decreases the risk of small cell carcinoma, squamous cell carcinoma and adenocarcinoma of the lung differently depending on their location in relation to micro-aspiration. Methods: Population-based cohort study including patients having undergone antireflux surgery during 1980–2014 in Denmark, Finland, Iceland, Norway or Sweden. Patients having undergone antireflux surgery were compared with two groups: 1) the corresponding background population, by calculating standardised incidence ratios (SIRs) with 95% confidence intervals (CIs) and 2) non-operated GERD-patients, by calculating hazard ratios (HRs) with 95% CIs using multivariable Cox regression with adjustment for sex, age, calendar period, country, chronic obstructive pulmonary disease and obesity diagnosis or type 2 diabetes. Results: Among all 812,617 GERD-patients, 46,996 (5.8%) had undergone antireflux surgery. The SIRs were statistically significantly decreased for small cell carcinoma (SIR = 0.57, 95% CI 0.41–0.77) and squamous cell carcinoma (SIR = 0.75, 95% CI 0.60–0.92), but not for adenocarcinoma of the lung (SIR = 0.90, 95% CI 0.76–1.06). The HRs were also below unity for small cell carcinoma (HR = 0.63, 95% CI 0.44–0.90) and squamous cell carcinoma (HR = 0.80, 95% CI 0.62–1.03), but not for adenocarcinoma of the lung (HR = 1.03, 95% CI 0.84–1.26). Analyses restricted to patients with objective GERD (reflux oesophagitis or Barrett's oesophagus) showed similar results. Conclusions: This all-Nordic study indicates that patients who undergo antireflux surgery are at decreased risk of small cell carcinoma and squamous cell carcinoma of the lung, but not of adenocarcinoma of the lung.

KW - Bronchus

KW - Fundoplication

KW - GERD

KW - GORD

KW - Neoplasm

KW - Nissen

KW - Pulmonary

UR - http://www.scopus.com/inward/record.url?scp=85089955558&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2020.07.018

DO - 10.1016/j.ejca.2020.07.018

M3 - Article

AN - SCOPUS:85089955558

VL - 138

SP - 80

EP - 88

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 1879-0852

ER -

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454